![](/img/cover-not-exists.png)
Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
Parente-Ribes, A., Skanland, S. S., Burgler, S., Os, A., Wang, D., Bogen, B., Tjonnfjord, G. E., Tasken, K., Munthe, L. A.Volume:
101
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2015.135590
Date:
February, 2016
File:
PDF, 1.18 MB
english, 2016